← Search & browse all drugs
CARDIOVASCULAR SYSTEM › ANTIHYPERTENSIVES › ANTIHYPERTENSIVES AND DIURETICS IN COMBINATION › Hydrazinophthalazine derivatives and diuretics
picodralazine and diuretics, combinations with psycholeptics
C02LG73
Forms & Strengths
- Fixed-dose combination: Picodralazine + Diuretic + Psycholeptic
- Oral tablet formulation
Adult Dosing
- Individualized titration based on blood pressure response and clinical status
- Typically administered once or twice daily as prescribed by hypertension guidelines
Pediatric Dosing
- Safety and efficacy not established in pediatric populations
- Not recommended for use in children
Indications
- Management of moderate to severe hypertension
- Hypertension complicated by anxiety or psychogenic components requiring adjunctive psycholeptic therapy
Mechanism of Action
- Picodralazine acts as a vasodilator to reduce peripheral vascular resistance
- Diuretic component promotes sodium and water excretion to reduce blood volume
- Psycholeptic component provides sedative or anxiolytic effects to reduce sympathetic tone
Contraindications
- Hypersensitivity to picodralazine, sulfonamide-derived diuretics, or psycholeptics
- Severe renal or hepatic impairment
- Anuria or acute electrolyte disturbances
- History of severe depression or central nervous system depression
Adverse Reactions
- Hypotension and orthostatic hypotension
- Dizziness, drowsiness, and sedation from psycholeptic component
- Electrolyte imbalances (hypokalemia, hyponatremia) from diuretic
- Gastrointestinal upset and dry mouth
- Headache and reflex tachycardia
Drug Interactions
- Enhancement of hypotensive effect with other antihypertensives, alcohol, or CNS depressants
- Increased risk of lithium toxicity when combined with diuretics
- Potential for additive sedation with other psychotropic medications
- Altered electrolyte levels affecting cardiac glycosides
Curated Content: Needs Vetting Before Put to Clinical Use